Dogwood Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11K Hold
44
﹤0.01% 660
2026
Q1
$1.62K Buy
+44
New +$2.08K ﹤0.01% 682
2025
Q2
Sell
-650
Closed -$45.9K 725
2025
Q1
$45.9K Buy
+650
New +$53.7K 0.02% 124

Other funds holding NVO

Dogwood Wealth Management's NVO Position: Q2 2026 in Review

Dogwood Wealth Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 44 shares worth $2.11K. The position accounts for ﹤0.01% of the portfolio, ranked #660.

Dogwood Wealth Management first reported a position in NVO in Q1 2025 and has held it in 3 quarters since. The position peaked at $45.9K in Q1 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Dogwood Wealth Management held 44 shares of Novo Nordisk worth $2.11K as of Q2 2026.
  • Dogwood Wealth Management left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #660 holding.
  • Dogwood Wealth Management first reported a position in Novo Nordisk in Q1 2025 and has held it in 3 quarters since.
  • Dogwood Wealth Management's Novo Nordisk position peaked at $45.9K in Q1 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.